1-10 of 10
Ana Maria Gonzalez-Angulo
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Genomic, Transcriptomic, and Proteomic Profiling of Metastatic Breast Cancer

Argun Akcakanat, Xiaofeng Zheng, Christian X. Cruz Pico, Tae-Beom Kim, Ken Chen, Anil Korkut, Aysegul Sahin, Vijaykumar Holla, Emily Tarco, Gopal Singh, Senthil Damodaran, Gordon B. Mills, Ana Maria Gonzalez-Angulo, Funda Meric-Bernstam
Journal: Clinical Cancer Research
Clin Cancer Res (2021) 27 (11): 3243–3252.
https://doi.org/10.1158/1078-0432.CCR-20-4048
Published: 01 June 2021
View articletitled, Genomic, Transcriptomic, and Proteomic Profiling of Metastatic Breast Cancer
Open the PDF for Genomic, Transcriptomic, and Proteomic Profiling of Metastatic Breast Cancer in another window
Includes: Supplementary data
Journal Articles

Influence of Biospecimen Variables on Proteomic Biomarkers in Breast Cancer

Funda Meric-Bernstam, Argun Akcakanat, Huiqin Chen, Aysegul Sahin, Emily Tarco, Selin Carkaci, Beatriz E. Adrada, Gopal Singh, Kim-Anh Do, Zerzhinski M. Garces, Elizabeth Mittendorf, Gildy Babiera, Isabelle Bedrosian, Rosa Hwang, Savitri Krishnamurthy, William F. Symmans, Ana Maria Gonzalez-Angulo, Gordon B. Mills
Journal: Clinical Cancer Research
Clin Cancer Res (2014) 20 (14): 3870–3883.
https://doi.org/10.1158/1078-0432.CCR-13-1507
Published: 14 July 2014
View articletitled, Influence of Biospecimen Variables on Proteomic Biomarkers in Breast Cancer
Open the PDF for Influence of Biospecimen Variables on Proteomic Biomarkers in Breast Cancer in another window
Includes: Supplementary data
Journal Articles

Emergence of Constitutively Active Estrogen Receptor-α Mutations in Pretreated Advanced Estrogen Receptor–Positive Breast Cancer

Rinath Jeselsohn, Roman Yelensky, Gilles Buchwalter, Garrett Frampton, Funda Meric-Bernstam, Ana Maria Gonzalez-Angulo, Jaime Ferrer-Lozano, Jose A. Perez-Fidalgo, Massimo Cristofanilli, Henry Gómez, Carlos L. Arteaga, Jennifer Giltnane, Justin M. Balko, Maureen T. Cronin, Mirna Jarosz, James Sun, Matthew Hawryluk, Doron Lipson, Geoff Otto, Jeffrey S. Ross, Addie Dvir, Lior Soussan-Gutman, Ido Wolf, Tamar Rubinek, Lauren Gilmore, Stuart Schnitt, Steven E. Come, Lajos Pusztai, Philip Stephens, Myles Brown, Vincent A. Miller
Journal: Clinical Cancer Research
Series: Author Choice
Clin Cancer Res (2014) 20 (7): 1757–1767.
https://doi.org/10.1158/1078-0432.CCR-13-2332
Published: 31 March 2014
View articletitled, Emergence of Constitutively Active Estrogen Receptor-α Mutations in Pretreated Advanced Estrogen Receptor–Positive Breast Cancer
Open the PDF for Emergence of Constitutively Active Estrogen Receptor-α Mutations in Pretreated Advanced Estrogen Receptor–Positive Breast Cancer in another window
Includes: Supplementary data
Journal Articles

Differential Response to Neoadjuvant Chemotherapy Among 7 Triple-Negative Breast Cancer Molecular Subtypes

Hiroko Masuda, Keith A. Baggerly, Ying Wang, Ya Zhang, Ana Maria Gonzalez-Angulo, Funda Meric-Bernstam, Vicente Valero, Brian D. Lehmann, Jennifer A. Pietenpol, Gabriel N. Hortobagyi, W. Fraser Symmans, Naoto T. Ueno
Journal: Clinical Cancer Research
Series: Author Choice
Clin Cancer Res (2013) 19 (19): 5533–5540.
https://doi.org/10.1158/1078-0432.CCR-13-0799
Published: 01 October 2013
View articletitled, Differential Response to Neoadjuvant Chemotherapy Among 7 Triple-Negative Breast Cancer Molecular Subtypes
Open the PDF for Differential Response to Neoadjuvant Chemotherapy Among 7 Triple-Negative Breast Cancer Molecular Subtypes in another window
Includes: Supplementary data
Journal Articles

Abstract A10: Peroxiredoxin-1 and oxidative stress: Controlling the balance between oncogenic and endocrine signalling in estrogen receptor-positive breast cancer

Patrick C. O'Leary, Donal J. Brennan, John Crown, William M. Gallagher, Radoslaw Zagozdzon, Yue Fan, Bryan T. Hennessy, Ana-Maria Gonzalez-Angulo, Gordon Mills, Fredrik Ponten, Karin Jirstrom, Mathias Uhlen, Darran O'Connor
Journal: Clinical Cancer Research
Clin Cancer Res (2012) 18 (10_Supplement): A10.
https://doi.org/10.1158/1078-0432.MECHRES-A10
Published: 04 March 2013
View articletitled, Abstract A10: Peroxiredoxin-1 and oxidative stress: Controlling the balance between oncogenic and endocrine signalling in estrogen receptor-positive breast cancer
Open the PDF for Abstract A10: Peroxiredoxin-1 and oxidative stress: Controlling the balance between oncogenic and endocrine signalling in estrogen receptor-positive breast cancer in another window
Journal Articles

Biomarkers of Response to Akt Inhibitor MK-2206 in Breast Cancer

Takafumi Sangai, Argun Akcakanat, Huiqin Chen, Emily Tarco, Yun Wu, Kim-Anh Do, Todd W. Miller, Carlos L. Arteaga, Gordon B. Mills, Ana Maria Gonzalez-Angulo, Funda Meric-Bernstam
Journal: Clinical Cancer Research
Clin Cancer Res (2012) 18 (20): 5816–5828.
https://doi.org/10.1158/1078-0432.CCR-12-1141
Published: 14 October 2012
View articletitled, Biomarkers of Response to Akt Inhibitor MK-2206 in Breast Cancer
Open the PDF for Biomarkers of Response to Akt Inhibitor MK-2206 in Breast Cancer in another window
Includes: Supplementary data
Journal Articles

PIK3CA/PTEN Mutations and Akt Activation As Markers of Sensitivity to Allosteric mTOR Inhibitors

Funda Meric-Bernstam, Argun Akcakanat, Huiqin Chen, Kim-Anh Do, Takafumi Sangai, Farrell Adkins, Ana Maria Gonzalez-Angulo, Asif Rashid, Katherine Crosby, Mei Dong, Alexandria T. Phan, Robert A. Wolff, Sanjay Gupta, Gordon B. Mills, James Yao
Journal: Clinical Cancer Research
Clin Cancer Res (2012) 18 (6): 1777–1789.
https://doi.org/10.1158/1078-0432.CCR-11-2123
Published: 14 March 2012
View articletitled, PIK3CA/PTEN Mutations and Akt Activation As Markers of Sensitivity to Allosteric mTOR Inhibitors
Open the PDF for PIK3CA/PTEN Mutations and Akt Activation As Markers of Sensitivity to Allosteric mTOR Inhibitors in another window
Includes: Supplementary data
Journal Articles

Integrative Analysis of Cyclin Protein Levels Identifies Cyclin B1 as a Classifier and Predictor of Outcomes in Breast Cancer

Roshan Agarwal, Ana-Maria Gonzalez-Angulo, Simen Myhre, Mark Carey, Ju-Seog Lee, Jens Overgaard, Jan Alsner, Katherine Stemke-Hale, Ana Lluch, Richard M. Neve, Wen Lin Kuo, Therese Sorlie, Aysegul Sahin, Vicente Valero, Khandan Keyomarsi, Joe W. Gray, Anne-Lise Borresen-Dale, Gordon B. Mills, Bryan T. Hennessy
Journal: Clinical Cancer Research
Clin Cancer Res (2009) 15 (11): 3654–3662.
https://doi.org/10.1158/1078-0432.CCR-08-3293
Published: 01 June 2009
View articletitled, Integrative Analysis of Cyclin Protein Levels Identifies Cyclin B1 as a Classifier and Predictor of Outcomes in Breast Cancer
Open the PDF for Integrative Analysis of Cyclin Protein Levels Identifies Cyclin B1 as a Classifier and Predictor of Outcomes in Breast Cancer in another window
Includes: Supplementary data
Journal Articles

A Systems Approach to Analysis of Molecular Complexity in Breast Cancer

Bryan T. Hennessy, Ana Maria Gonzalez-Angulo, Mark S. Carey, Gordon B. Mills
Journal: Clinical Cancer Research
Clin Cancer Res (2009) 15 (2): 417–419.
https://doi.org/10.1158/1078-0432.CCR-08-2620
Published: 15 January 2009
View articletitled, A Systems Approach to Analysis of Molecular Complexity in Breast Cancer
Open the PDF for A Systems Approach to Analysis of Molecular Complexity in Breast Cancer in another window
Includes: Supplementary data
Journal Articles

Pharmacodynamic Markers of Perifosine Efficacy

Bryan T. Hennessy, Yiling Lu, Enrique Poradosu, Qianghua Yu, Shuangxing Yu, Hassan Hall, Mark S. Carey, Murali Ravoori, Ana Maria Gonzalez-Angulo, Robert Birch, I. Craig Henderson, Vikas Kundra, Gordon B. Mills
Journal: Clinical Cancer Research
Clin Cancer Res (2007) 13 (24): 7421–7431.
https://doi.org/10.1158/1078-0432.CCR-07-0760
Published: 19 December 2007
View articletitled, Pharmacodynamic Markers of Perifosine Efficacy
Open the PDF for Pharmacodynamic Markers of Perifosine Efficacy in another window
Includes: Supplementary data